About Celerix
Celerix is a company based in Bengaluru (India) founded in 2013 by Kusuma Kumari Garapati and Nagesh Kodavali. Celerix has raised $711.49 thousand across 5 funding rounds from investors including Touchstone Equities, Bitkemy Technologies and Aakraya Research. The company has 20 employees as of April 08, 2024. Celerix offers products and services including Impetus, Market Triggers, and IP Cores. Celerix operates in a competitive market with competitors including Xilinx, Altera, Achronix, QuickLogic and EFinix, among others.
- Headquarter Bengaluru, India
- Employees 20 as on 08 Apr, 2024
- Founders Kusuma Kumari Garapati, Nagesh Kodavali
- Stage Minicorn
-
Sectors
Technology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Celerix Infotech Private Limited
- Date of Incorporation 25 Apr, 2012
- Jurisdiction Bangalore Urban, Karnataka, India
-
Annual Revenue
$411.46 K (USD)32.92as on Mar 31, 2022
-
Net Profit
$165.4 (USD)-99.73as on Mar 31, 2022
-
EBITDA
$101.26 K (USD)-33.71as on Mar 31, 2022
-
Total Equity Funding
$711.49 K (USD)
in 5 rounds
-
Latest Funding Round
$13.97 K (USD), Seed
Jan 31, 2020
-
Investors
Touchstone Equities
& 2 more
-
Employee Count
20
as on Apr 08, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Celerix
Celerix offers a comprehensive portfolio of products and services, including Impetus, Market Triggers, and IP Cores.
Hardware-based System-on-Chip for sub-microsecond trading execution.
Hardware solution for low-latency trade condition processing.
Turnkey solutions to reduce tick-to-trade latency via FPGA.
People of Celerix
Unlock access to complete
Unlock access to complete
Funding Insights of Celerix
Celerix has successfully raised a total of $711.49K across 5 strategic funding rounds. The most recent funding activity was a Seed round of $13.97 thousand completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Seed — $13,969
-
First Round
First Round
(14 Dec 2015)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Seed - Celerix | Valuation | Aakraya Research |
|
| Dec, 2018 | Amount | Seed - Celerix | Valuation | Touchstone Equities |
|
| Nov, 2017 | Amount | Seed - Celerix | Valuation | Touchstone Equities |
|
Investors in Celerix
Celerix has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Touchstone Equities, Bitkemy Technologies and Aakraya Research.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm investing in early-stage tech startups
|
Founded Year | Domain | Location | |
|
IT services, software development, and consulting solutions provided globally.
|
Founded Year | Domain | Location | |
|
Develops trading strategies using machine learning and statistics for investment markets.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Celerix
Financial Statements - Celerix
Celerix Comparisons
Competitors of Celerix
Celerix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Xilinx, Altera, Achronix, QuickLogic and EFinix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Programmable logic devices and embedded solutions are provided.
|
|
| domain | founded_year | HQ Location |
Programmable logic devices and reconfigurable digital circuits are manufactured.
|
|
| domain | founded_year | HQ Location |
AI-based field-programmable gate arrays and IPs are manufactured.
|
|
| domain | founded_year | HQ Location |
Low-power field programmable gate arrays are designed and developed.
|
|
| domain | founded_year | HQ Location |
Programmable logic cores are provided to silicon companies by EFinix.
|
|
| domain | founded_year | HQ Location |
AI-enabled field-programmable gate array devices are developed and supplied.
|
Frequently Asked Questions about Celerix
Celerix was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Celerix is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Celerix is a funded company, having raised a total of $711.49K across 5 funding rounds to date. The company's 1st funding round was a Seed of $77.04K, raised on Dec 14, 2015.
As of Apr 08, 2024, the latest employee count at Celerix is 20.
Annual revenue of Celerix is $411.46K as on Mar 31, 2022.
Celerix was founded in 2013 in Bengaluru, India, as a provider of FPGA-based solutions for high-performance trading in global financial markets. Hardware systems, including system-on-chip designs and trade execution platforms, along with intellectual property cores, are developed to minimize tick-to-trade latency. Custom FPGA modules and systems are created, existing setups are ported to FPGA, and performance engineering consultations are offered for low-latency enhancements.
Celerix offers Impetus, Market Triggers, and IP Cores.
Celerix has 3 investors. Key investors include Touchstone Equities, Bitkemy Technologies, and Aakraya Research.
The valuation of Celerix is $3.51M as of Jan 2020.